Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine effects on CSF monoamine metabolites in schizophrenia
2006-002342-11Phase 4Active
- Sponsor
- Klinikum Fulda
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in schizophrenia, sponsored by Klinikum Fulda. Primary endpoint: Primary objective biomarker endpoint. Started Jan 2007; status: active.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-002342-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002342-11.